TITLE

Assessment of Bone Marrow Fibrosis and Angiogenesis in Monitoring Patients With Multiple Myeloma

AUTHOR(S)
Babarović, Emina; Valković, Toni; Štifter, Sanja; Budisavljević, Ivana; Seili-Bekafigo, Irena; Duletić-Načinović, Antica; Lučin, Ksenija; Jonjić, Nives
PUB. DATE
June 2012
SOURCE
American Journal of Clinical Pathology;Jun2012, Vol. 137 Issue 6, p871
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The aim of our study was to emphasize the importance of accurate and standardized techniques for detailed monitoring of the microenvironment in multiple myeloma (MM). Bone marrow fibrosis, angiogenesis, and plasma cell infiltrates in bone marrow biopsy (BMB) samples at the time of diagnosis and on completion of therapy were analyzed for 42 patients with newly diagnosed MM. Computerized image analysis was used for all slides stained with anti-CD138 and anti-CD34. The patients with fibrosis in pretreatment BMB samples had significantly higher microvessel density (MVD) and plasma cell infiltrates. In posttreatment BMB samples, nonresponders had a significantly higher frequency and grade of fibrosis and higher values of MVD, total vascular area, and plasma cell percentage. The overall survival of nonresponders and patients with increased marrow fibrosis in posttreatment BMB samples was significantly shorter. The obtained results confirm that complex morphologic examination of the bone marrow microenvironment during the monitoring of MM can provide better prognostic significance.
ACCESSION #
76356673

 

Related Articles

  • Multiple primary cutaneous plasmacytomas. Fitzhugh, V. A.; Siegel, D.; Bhattacharyya, P. K. // Journal of Clinical Pathology;Jun2008, Vol. 61 Issue 6, p782 

    The article offers information on multiple primary cutaneous plasmacytomas. Multiple myeloma and solitary plasmacytoma occur in the bone marrow and extramedullary sites such as upper respiratory and gastrointestinal tracts. Lesions are commonly found on the face, trunk and extremities....

  • Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets. Hideshima, Teru; Mitsiades, Constantine; Tonon, Giovanni; Richardson, Paul G.; Anderson, Kenneth C. // Nature Reviews Cancer;Aug2007, Vol. 7 Issue 8, p585 

    Multiple myeloma is a plasma cell malignancy characterized by complex heterogeneous cytogenetic abnormalities. The bone marrow microenvironment promotes multiple myeloma cell growth and resistance to conventional therapies. Although multiple myeloma remains incurable, novel targeted agents, used...

  • PTTG1 expression is associated with hyperproliferative disease and poor prognosis in multiple myeloma. Noll, Jacqueline E.; Vandyke, Kate; Hewett, Duncan R.; Mrozik, Krzysztof M.; Bala, Rachel J.; Williams, Sharon A.; Kok, Chung H.; Zannettino, Andrew C. W. // Journal of Hematology & Oncology;10/7/2015, Vol. 8 Issue 1, p1 

    Background: Multiple myeloma (MM) is an incurable haematological malignancy characterised by the clonal proliferation of malignant plasma cells within the bone marrow. We have previously identified pituitary tumour transforming gene 1 (Pttg1) as a gene that is significantly upregulated in the...

  • Bone marrow angiogenesis and its correlation with other disease characteristics in multiple myeloma in stage I versus stage II-III. Niemöller, Kathrin; Jakob, Christian; Heider, Ulrike; Zavrski, Ivana; Eucker, Jan; Kaufmann, Olaf; Possinger, Kurt; Sezer, Orhan // Journal of Cancer Research & Clinical Oncology;Apr2003, Vol. 129 Issue 4, p234 

    Purpose. We studied bone marrow angiogenesis in different stages of multiple myeloma according to the Durie and Salmon classification and its correlations with other disease characteristics. Methods. Sixty-five immunohistochemical CD34-stained, paraffin-embedded bone marrow biopsies of multiple...

  • Relationship between bone marrow angiogenesis and plasma cell infiltration and serum beta2-microglobulin levels in patients with multiple myeloma. Sezer, O.; Niemöller, K.; Jakob, C.; Zavrski, I.; Heider, U.; Eucker, J.; Kaufmann, O.; Possinger, K.; Niemöller, K // Annals of Hematology;Oct2001, Vol. 80 Issue 10, p598 

    There is growing evidence that angiogenesis is important not only in solid tumors but also in hematological malignancies. Recently, we found that bone marrow angiogenesis is a prognostic factor for disease-related survival in patients with multiple myeloma. In this report, we addressed the...

  • Bone Marrow Angiogenesis and Plasma Cell Angiogenic and Invasive Potential in Patients with Active Multiple Myeloma. Vacca, Angelo; Ribatti, Domenico; Roccaro, Aldo M.; Ria, Roberto; Palermo, Loredana; Dammacco, Franco // Acta Haematologica;2001, Vol. 106 Issue 4, p162 

    Factor VIII-related antigen-positive microvessel areas were measured by both immunohistochemistry and computerized image analysis in patients with active multiple myeloma (MM), nonactive MM and monoclonal gammopathies of undetermined significance (MGUS). A 5- to 6-fold larger area was found in...

  • Myeloma Cells and Their Interactions With the Bone Marrow Endothelial Cells. De Bruyne, Elke; Menu, Eline; Van Valckenborgh, Els; De Raeve, Hendrik; Van Camp, Ben; Van Riet, Ivan; Vanderkerken, Karin // Current Immunology Reviews;2007, Vol. 3 Issue 1, p41 

    Multiple myeloma (MM) is an incurable plasma cell malignancy characterized by a monoclonal proliferation of plasma cells in the bone marrow (BM), secretion of paraprotein in serum, development of osteolytic bone lesions and angiogenesis in the BM. In the BM, MM cells receive signals to survive...

  • 14q32 chromosomal translocations: a hallmark of plasma cell dyscrasias? Avet-Loiseau, Hervé; Minvielle, Stéphane; Mellerin, Marie-Paule; Magrangeas, Florence; Bataille, Régis // Hematology Journal;2000, Vol. 1 Issue 5, p292 

    The Hematology Journal (2000) 1, 292–294

  • Differential expression of Bcl-2 in human plasma cell disorders according to proliferation status and malignancy. Puthier, D; Pellat-Deceunynck, C; Barillé, S; Robillard, N; Rapp, M-J; Juge-Morineau, N; Harousseau, J-L; Bataille, R; Amiot, M // Leukemia (08876924);Feb99, Vol. 13 Issue 2, p289 

    Multiple myeloma (MM) is a malignancy characterized by a very slow proliferation of malignant plasma cells leading to their accumulation within the bone marrow. This suggests that resistance to apoptosis may play a critical role both in the pathogenesis and resistance to treatment of MM. Bcl-2...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics